Raisting\/Hanover \u2014 NORD Holding Unter\u00adneh\u00admens\u00adbe\u00adtei\u00adli\u00adgungs\u00adge\u00adsell\u00adschaft mbH (\u201cNORD Holding\u201d) has sold its majo\u00adrity share\u00adhol\u00adding in hg medi\u00adcal, a leading contract manu\u00adfac\u00adtu\u00adrer of high-quality ortho\u00adpe\u00addic implants, to Astorg Mid-Cap (\u201cAstorg\u201d).<\/p>\n
hg medi\u00adcal is a leading provi\u00adder of high-quality ortho\u00adpe\u00addic implants with a focus on lower extre\u00admi\u00adties, upper extre\u00admi\u00adties and the spine. With state-of-the-art faci\u00adli\u00adties in Germany and the U.S., the company diffe\u00adren\u00adtia\u00adtes itself as a leading provi\u00adder in the extre\u00admi\u00adties segment. The compre\u00adhen\u00adsive range of services is geared to the ever-chan\u00adging needs of custo\u00admers and includes design and deve\u00adlo\u00adp\u00adment, proto\u00adty\u00adp\u00ading, vali\u00adda\u00adtion and produc\u00adtion of complex and high-quality implants.<\/p>\n
The company works closely with physi\u00adci\u00adans and hospi\u00adtals to ensure that implants meet pati\u00adent care requi\u00adre\u00adments. hg medi\u00adcal\u2019s excel\u00adlent repu\u00adta\u00adtion is based on compre\u00adhen\u00adsive tech\u00adni\u00adcal know-how, high-quality manu\u00adfac\u00adtu\u00adring and outstan\u00adding custo\u00admer service. Through part\u00adner\u00adships with fast-growing chal\u00adlen\u00adger and blue-chip OEMs and a strong custo\u00admer focus, hg medi\u00adcal has reali\u00adzed excep\u00adtio\u00adnal growth over the past 16 years.<\/p>\n
With the acqui\u00adsi\u00adtion of hg medi\u00adcal by NORD Holding in 2020, hg medi\u00adcal, led by CEO and foun\u00adder Johan\u00adnes Hagen\u00admeyer, COO Craig Bluett, and CFO J\u00fcrgen Stef\u00adfen\u00adsen, has been posi\u00adtio\u00adned as a global leader in the ortho\u00adpe\u00addic implant market.<\/p>\n
Andre Seidel, part\u00adner of NORD Holding<\/strong> (photo \u00a9 Nord\u00adhol\u00adding), explains: \u201cWe are very proud and impres\u00adsed by the deve\u00adlo\u00adp\u00adment of hg medi\u00adcal in recent years. NORD Holdin\u00adg\u2019s health\u00adcare team, NORD Holdin\u00adg\u2019s opera\u00adti\u00adons team, and manage\u00adment have taken hg medi\u00adcal to the next level by impro\u00adving finan\u00adcial trans\u00adpa\u00adrency, opti\u00admi\u00adzing proces\u00adses, and incre\u00adasing produc\u00adtion capa\u00adcity for future growth. We are also very plea\u00adsed because hg medi\u00adcal was one of our first invest\u00adments based on our dedi\u00adca\u00adted health\u00adcare invest\u00adment approach.\u201d<\/p>\n In view of the incre\u00adasing global demand for ortho\u00adpe\u00addic implants, hg medi\u00adcal is very well posi\u00adtio\u00adned to conti\u00adnue on its growth path and main\u00adtain its posi\u00adtion as a leading supplier in the indus\u00adtry. Astor\u00adg\u2019s invest\u00adment will enable the company to further expand its capa\u00adcity and range of services to meet the growing demand for outsour\u00adced manu\u00adfac\u00adtu\u00adring in the ortho\u00adpe\u00addic sector.<\/p>\n Consul\u00adtant NORD Holding:<\/strong> About hg medical About Astorg About NORD Holding On the part of NORD Holding, the tran\u00adsac\u00adtion was imple\u00admen\u00adted by Andr\u00e9 Seidel, Jan-Phil\u00adipp Wilckens, David W\u00f6ss\u00adner and Nico\u00adlas Eiden\u00adm\u00fcl\u00adler. www.nordholding.de<\/p>\n","protected":false},"excerpt":{"rendered":" Raisting\/Hanover \u2014 NORD Holding Unter\u00adneh\u00admens\u00adbe\u00adtei\u00adli\u00adgungs\u00adge\u00adsell\u00adschaft mbH (\u201cNORD Holding\u201d) has sold its majo\u00adrity share\u00adhol\u00adding in hg medi\u00adcal, a leading contract manu\u00adfac\u00adtu\u00adrer of high-quality ortho\u00adpe\u00addic implants, to Astorg Mid-Cap (\u201cAstorg\u201d). hg medi\u00adcal is a leading provi\u00adder of high-quality ortho\u00adpe\u00addic implants with a focus on lower extre\u00admi\u00adties, upper extre\u00admi\u00adties and the spine. With state-of-the-art faci\u00adli\u00adties in Germany and [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":48545,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1368,1369,1377,1380],"tags":[],"class_list":["post-48547","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors","category-corporate-finance-ma","category-management-consultants-investor-relations-en"],"yoast_head":"\n
\nTD Cowen (M&A)
\nMilbank (Legal)
\nAlva\u00adrez & Marsal (Commer\u00adcial)
\nDeloitte (Finan\u00adcial)
\nFlick Gocke Schaum\u00adburg and Alva\u00adrez & Marsal (Tax)
\nTAUW (ESG)<\/p>\n
\n<\/strong>
\nhg medi\u00adcal, based in Rais\u00adting, Germany, is a leading contract manu\u00adfac\u00adtu\u00adrer of high-quality ortho\u00adpe\u00addic implants with a focus on lower extre\u00admi\u00adties, upper extre\u00admi\u00adties and in the spine area. hg medi\u00adcal\u2019s custo\u00admers deve\u00adlop products that improve the quality of life for many pati\u00adents world\u00adwide. hg medi\u00adcal supports them in successfully imple\u00admen\u00adting their ideas in a highly compe\u00adti\u00adtive envi\u00adron\u00adment. www.hg-medical.de<\/p>\n
\n<\/strong>
\nAstorg is a Euro\u00adpean private equity company with a assets under manage\u00adment of over \u20ac 20 billion.<\/strong> Astorg works with entre\u00adpre\u00adneurs and manage\u00adment teams to acquire market-leading, global compa\u00adnies head\u00adquar\u00adte\u00adred in Europe, provi\u00adding them with the stra\u00adte\u00adgic guidance, corpo\u00adrate leader\u00adship and capi\u00adtal they need to achieve their growth objec\u00adti\u00adves. Astorg has a strong entre\u00adpre\u00adneu\u00adrial culture, a long-term share\u00adhol\u00adder perspec\u00adtive and a lean decis\u00adion-making body. Astorg has valuable indus\u00adtry exper\u00adtise in health\u00adcare, soft\u00adware and tech\u00adno\u00adlogy, busi\u00adness services, and tech\u00adno\u00adlogy-based indus\u00adtrial compa\u00adnies. The offices are loca\u00adted in London, Paris, New York, Frank\u00adfurt, Milan and Luxembourg.<\/p>\n
\n<\/strong>
\nWith over 50 years of history and assets under manage\u00adment of \u20ac 3.0 billion, NORD Holding is one of the leading private equity and asset manage\u00adment compa\u00adnies in Germany. The focus is on the busi\u00adness areas of direct invest\u00adments and fund invest\u00adments. The focus of the direct busi\u00adness is on the struc\u00adtu\u00adring and finan\u00adcing of corpo\u00adrate succes\u00adsion models, the acqui\u00adsi\u00adtion of group parts\/subsidiaries and the expan\u00adsion finan\u00adcing of medium-sized compa\u00adnies. In contrast to most other finan\u00adcial inves\u00adtors, who only manage time-limi\u00adted funds, NORD Holding acts as a so-called \u201cever\u00adgreen fund\u201d with no time limit and invests from its own balance sheet. The company is curr\u00adently invol\u00adved with more than 15 compa\u00adnies in Germany and other German-spea\u00adking count\u00adries. The Fund Invest\u00adments busi\u00adness unit targets the micro and small cap segment of mid-market-orien\u00adted private equity funds in Europe. The focus here is on primary, secon\u00addary and co-invest\u00adments. NORD Holding focu\u00adses stron\u00adgly on buyout mana\u00adgers newly estab\u00adlished on the market, opera\u00adtio\u00adnal invest\u00adment stra\u00adte\u00adgies and also regu\u00adlarly acts as an anchor investor.<\/p>\n